mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Crown Use during the coronavirus (COVID-19) pandemic
Matthew Naylor - April 9, 2020

Crown Use during the coronavirus (COVID-19) pandemic

As discussed in a previous blog, the UK Government has the power to authorise (either in advance, ...

Why a
Rebecca Anderson-Smith - April 9, 2020

Why a "COVID-19” trade mark should be rejected

The COVID-19 pandemic has undoubtedly forced us all to adapt our lives and business practices in ...

Taking charge - repurposing, recycling and reinventing batteries
Callum McGuinn - April 7, 2020

Taking charge - repurposing, recycling and reinventing batteries

Innovation in repurposing, recycling and reinventing batteries will be a rich vein of IP, say ...

What use is computational biology during the coronavirus (COVID-19) pandemic?
Camille Terfve - April 6, 2020

What use is computational biology during the coronavirus (COVID-19) pandemic?

There is one obvious way in which computational biology is showing its strengths in the current ...

3D printing community responds to the coronavirus (COVID-19) challenge
Jacqueline Murphy - April 3, 2020

3D printing community responds to the coronavirus (COVID-19) challenge

The coronavirus (COVID19) pandemic has left healthcare systems globally scrambling for much needed ...

Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective
Andrew Pitts - April 3, 2020

Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective

Recent interesting reports highlight an emerging practice borne out of necessity in which medical ...

A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)
Eliot Ward - April 2, 2020

A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)

Our Singapore based-clients A*STAR (Agency for Science, Technology and Research) and MiRXES are ...

New partner promotion and director appointments
Maria Hall - April 1, 2020

New partner promotion and director appointments

We are delighted to announce five new roles across three of our offices.

Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy
Anna Mudge - March 31, 2020

Neoantigen-targeted adoptive cell therapies – the next frontier in cancer immunotherapy

Cancer immunotherapies harness the power of the patient’s immune system to destroy malignant cells ...

CRISPR used in gene editing clinical trial for first time
Sean Constable - March 30, 2020

CRISPR used in gene editing clinical trial for first time

The revolutionary CRISPR gene editing tool has been used inside the human body for the first time ...

German Constitutional Court Verdict: Stumbling Block or Death Knell for the UPC?
Tanis Keirstead - March 26, 2020

German Constitutional Court Verdict: Stumbling Block or Death Knell for the UPC?

On 20 March 2020, three years after the challenge was originally brought, the German Constitutional ...

Microbiome: Meet your multitude
Eliot Ward - March 25, 2020

Microbiome: Meet your multitude

The health and wellbeing of each of us depends upon a number of vast communities of microbes that ...

Coronavirus (COVID-19): a case study in emerging disease
Tanis Keirstead - March 24, 2020

Coronavirus (COVID-19): a case study in emerging disease

UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production, we explore pressing need to ...

Pushing Energy Storage to the MX(ene)
Alison Fugard - March 24, 2020

Pushing Energy Storage to the MX(ene)

Batteries are indispensable in modern life. Not only is our reliance on batteries increasing with ...

Vaccine platform technologies to combat emerging infectious diseases
Lucy White - March 23, 2020

Vaccine platform technologies to combat emerging infectious diseases

The SARS-CoV-2 outbreak is now a global pandemic. In a previous post, we discussed the need to act ...

Changes to our correspondence address
Richard Clegg - March 20, 2020

Changes to our correspondence address

In response to the current situation in London due to Coronavirus (COVID-19) we are redirecting all ...

Parallel imports of pharmaceuticals – A UK trade mark perspective
Rebecca Anderson-Smith - March 19, 2020

Parallel imports of pharmaceuticals – A UK trade mark perspective

The UK parallel import licensing scheme lets a medicine authorised in another EU Member State be ...

Bioinformatics - science's big secret
Camille Terfve - March 18, 2020

Bioinformatics - science's big secret

Now deeply woven into the fabric of biological research, bioinformatics has become the secret sauce ...

Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended!
Willum Wytenburg - March 16, 2020

Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended!

Part 2 of this blog was published on 17 April 2020. Please read for the latest information. News ...

Oppositions & Appeals: We set the standard for the strawman
Seán Walton - March 12, 2020

Oppositions & Appeals: We set the standard for the strawman

Case 5 - T 649/92 (EPO Enlarged Board of Appeal, 2 July 1996)

Making Waves
Sean Jauss - March 11, 2020

Making Waves

I guess it isn't all that surprising that it was tricky to get Nick Hounsfield and Craig Stoddart ...

Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine
Camille Terfve - March 9, 2020

Bioinformatics, data and healthcare: Benefits and challenges of data-driven medicine

Algorithms (sometimes collectively referred to as ‘digital health’) are changing the way that ...

When the sky is not the limit: Issues facing businesses when expanding services and products
Kate O'Rourke - March 9, 2020

When the sky is not the limit: Issues facing businesses when expanding services and products

Conflicting views on the legitimacy of filing trademarks with broad lists of goods and services ...

Why 'innoversity' is an imperative
Sarah Kostiuk-Smith - March 6, 2020

Why 'innoversity' is an imperative

Andrea Brewster, lead executive officer at IP Inclusive, writes for Forward magazine. She discusses ...

Finding the “lost Einsteins” of innovation
Frances Salisbury - March 6, 2020

Finding the “lost Einsteins” of innovation

Sarah Kostiuk-Smith, Partner and European Patent Attorney at Mewburn Ellis, examines the glaring ...

Latest in Halloumi trade mark dispute
Rebecca Anderson-Smith - March 5, 2020

Latest in Halloumi trade mark dispute

In July 2014, Bulgarian company M. J. Dairies EOOD filed a European Union trade mark application ...

What’s in a name? Enforcing trade mark rights and the own name defence
Rebecca Anderson-Smith - March 3, 2020

What’s in a name? Enforcing trade mark rights and the own name defence

Clothing and accessories brand Hugo Boss has recently found itself making headlines, and probably ...

Coronavirus (COVID-19) Update
Richard Clegg - March 3, 2020

Coronavirus (COVID-19) Update

Updated: 2pm Sunday 1st November 2020

Chemical collaborations: polymer partnerships
Niles Beadman - February 26, 2020

Chemical collaborations: polymer partnerships

Collaboration is ubiquitous with successful research. Sharing results generates new leads, sharing ...

Lithium-sulfur batteries - an attractive alternative
Callum McGuinn - February 26, 2020

Lithium-sulfur batteries - an attractive alternative

Lithium-ion (Li-ion) batteries are a ubiquitous energy source in modern society, powering our ...

EPO streamlining: the opposition timeline tightens
Katherine Green - February 24, 2020

EPO streamlining: the opposition timeline tightens

Our analysis of patent oppositions has revealed that early action has become imperative for ...

2020 BioInfect Conference - tackling antimicrobial resistance
Anna Mudge - February 21, 2020

2020 BioInfect Conference - tackling antimicrobial resistance

Antimicrobial resistance (AMR) poses a global threat. No new classes of antibiotics have been ...

Darobactin – worming our way out of antibiotic resistance
Alison Fugard - February 21, 2020

Darobactin – worming our way out of antibiotic resistance

Recently, we have been exploring antimicrobial resistance and the possible solutions to this ...

Sky v Skykick - status quo remains for trade mark owners
Andy King - February 20, 2020

Sky v Skykick - status quo remains for trade mark owners

Background Sky, the TV, broadcasting, media and telecommunications giant, brought infringement and ...

What makes Massachusetts small but mighty?
Anna Mudge - February 19, 2020

What makes Massachusetts small but mighty?

Deirdre Sanders, president of the Boston Patent Law Association and a principle at Hamilton Brook ...

The evolutionary history of cancer - predicting the disease
Nick Sutcliffe - February 18, 2020

The evolutionary history of cancer - predicting the disease

Cells can acquire the mutations that drive the development of cancer many years before the patient ...

World Trademark Review 1000: The World’s Leading Trademark Professionals 2020
Jacqueline Murphy - February 17, 2020

World Trademark Review 1000: The World’s Leading Trademark Professionals 2020

Mewburn Ellis is delighted to once again be ranked in World Trade Mark Review 1000, the research ...

Genomics and Biodata in 2020: the future is here!
Camille Terfve - February 14, 2020

Genomics and Biodata in 2020: the future is here!

I have been working in the field of bioinformatics/computational biology for 10 years now and have ...

Oppositions & Appeals: we opened the door for different types of data to support a medical use 
Richard Clegg - February 12, 2020

Oppositions & Appeals: we opened the door for different types of data to support a medical use 

Case 4 - T 801/06 (EPO Board of Appeal, 4 March 2009)

Genetic engineering and synthetic biology – making cannabis production greener
Thomas Driver - February 6, 2020

Genetic engineering and synthetic biology – making cannabis production greener

The therapeutic benefits of medicinal cannabis have been liberally splashed across newspaper ...

Enleofen strikes Singapore’s biggest ever biotech deal
Adam Gregory - February 4, 2020

Enleofen strikes Singapore’s biggest ever biotech deal

In January it was announced that global pharmaceutical company Boehringer Ingelheim has acquired ...

Patenting the Internet of Things – the European perspective
John Addiss - February 4, 2020

Patenting the Internet of Things – the European perspective

It is estimated that by 2025 there will be 26-30 billion devices in the workplace and home equipped ...

Munich office expansion with high-profile lateral hire
Maria Hall - February 3, 2020

Munich office expansion with high-profile lateral hire

We are delighted to announce the high-profile appointment of Dr. Thomas Wolter into our Munich ...

Farming the great indoors
Adam Gregory - January 30, 2020

Farming the great indoors

When you think of a farm, what comes to mind? Rolling fields of green new growth, and carpets of ...

Advancements of genetic testing
Katherine Collins - January 29, 2020

Advancements of genetic testing

The sequencing of the first human genome in 2003 was a major breakthrough in genomics. While this ...

Oppositions & Appeals: We made the case for a new technical effect
Simon Kiddle - January 29, 2020

Oppositions & Appeals: We made the case for a new technical effect

Case 3 - T 1642/06 (EPO Board of Appeal, 23 August 2007)

EPO announces fee increases from 1 April 2020
Willum Wytenburg - January 27, 2020

EPO announces fee increases from 1 April 2020

In recent times, the European Patent Office (EPO) has increased its official fees every two years. ...

A promising target for new antibiotics
Jane Liu - January 23, 2020

A promising target for new antibiotics

In previous blogs we have discussed the global threat of antimicrobial resistance and some of the ...

Welcome to our new website
Jacqueline Murphy - January 23, 2020

Welcome to our new website

We are delighted to announce the launch of our new website, it incorporates the very best of the ...

Proud Partners of the Graphene Engineering Innovation Centre (GEIC)
Jacqueline Murphy - January 23, 2020

Proud Partners of the Graphene Engineering Innovation Centre (GEIC)

We are proud and excited to be starting our second year as an affiliate partner of the Graphene ...

Simulations in bioinformatics and the G1/19 referral
Camille Terfve - January 23, 2020

Simulations in bioinformatics and the G1/19 referral

What’s all this about? Claims directed to methods of simulation or modelling of a system or process ...

AI: Machine learning - the when’s and the how’s of machine learning
James Leach - January 20, 2020

AI: Machine learning - the when’s and the how’s of machine learning

In our recent post on the use of artificial intelligence in bioinformatics, it was highlighted that ...

EPO Board of Appeal confirms Broad Institute’s CRISPR patent lacks priority and upholds revocation decision
Sean Constable - January 17, 2020

EPO Board of Appeal confirms Broad Institute’s CRISPR patent lacks priority and upholds revocation decision

In one of the most high profile cases of recent years, a European Patent Office (EPO) Board of ...

JUVE Patent UK ranking 2020
Jacqueline Murphy - January 8, 2020

JUVE Patent UK ranking 2020

We are delighted to be recommended in JUVE's Patent UK ranking 2020 which recognises patent ...

AI, deep learning and image analysis in bioinformatics
Camille Terfve - January 2, 2020

AI, deep learning and image analysis in bioinformatics

Putting “AI” in the title of your paper, or indeed in the name of your company, seems to have ...

Graphene Composites: 5 things we can learn from the IP data
Matthew Smith - December 18, 2019

Graphene Composites: 5 things we can learn from the IP data

The European Patent Office (EPO) recently released some initial data about patenting activity in ...

Will biomarkers come of age?
Anna Mudge - December 18, 2019

Will biomarkers come of age?

The world’s population is ageing. In 2018, for the first time in history, people aged 65 or above ...

Sustainability: Graphene offers new opportunities
Alison Fugard - December 18, 2019

Sustainability: Graphene offers new opportunities

In our blog Green graphene - the pursuit of sustainability we looked at methods for the production ...

The 12 elements of Christmas...
Joseph Newcombe - December 17, 2019

The 12 elements of Christmas...

16O Chemistree, 16O Chemistree, how lovely are your elements… As 2019 draws to a close, so too does ...

Bioinformatics: biological and medical sciences in the age of big data
Camille Terfve - December 16, 2019

Bioinformatics: biological and medical sciences in the age of big data

What is bioinformatics? Bioinformatics is a term which we will use as an umbrella to encompass work ...

Bioinformatics is everywhere!
Camille Terfve - December 16, 2019

Bioinformatics is everywhere!

As discussed in a previous post, most types of biological or medical data that can be collected ...

Collagen scaffolds – the future of tissue engineering?
Isobel Stone - December 16, 2019

Collagen scaffolds – the future of tissue engineering?

Despite the success of organ transplantation since its inception in the 20th century, people today ...

AI: Machine learning - what is the machine actually learning?
James Leach - December 13, 2019

AI: Machine learning - what is the machine actually learning?

Following on from Richard Johnson’s blog post “Inventive AI: can machines innovate?” we now focus ...

Indian Patent Office adopts the Patent Prosecution Highway programme
Rachel Oxley - December 11, 2019

Indian Patent Office adopts the Patent Prosecution Highway programme

Recently, the Indian Union Cabinet approved a proposal for the Indian Patent Office (IPO) to adopt ...

Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy
Eliot Ward - December 6, 2019

Gamma/delta T cells emerge as an untapped resource for cancer immunotherapy

Third lymphocyte lineage shows its mettle B lymphocytes, a type of white blood cell that is ...

3 R's for sustainability of the battery industry
Joseph Newcombe - December 5, 2019

3 R's for sustainability of the battery industry

Zero-carbon transport and energy production are set to grow under the shadow of global warming and ...

Rubik’s Cube trade mark in puzzling General Court decision
Andy King - December 4, 2019

Rubik’s Cube trade mark in puzzling General Court decision

This article was originally published on the CITMA website. View the original article here. Ruling ...

The Aboriginal flag dispute in focus: who owns the right to use?
Kate O'Rourke - December 2, 2019

The Aboriginal flag dispute in focus: who owns the right to use?

The Australian government is considering whether to compulsorily acquire the rights to use the ...

Australian innovation patent system - the end is near
William Hey - November 28, 2019

Australian innovation patent system - the end is near

The Australian innovation patent system is on its last legs, which could spell bad news for SMEs ...

Biomarkers and precision medicine
Anna Mudge - November 27, 2019

Biomarkers and precision medicine

A biomarker, an amalgamation of the term ‘biological marker’, is a measurable indicator of a ...

General Court annuls incorrect interpreted specification of trade mark
Rebecca Anderson-Smith - November 27, 2019

General Court annuls incorrect interpreted specification of trade mark

We are delighted to report that our client Alliance Pharmaceuticals Limited has been successful in ...

Lithium-ion batteries - powering the EVs of the future
Callum McGuinn - November 20, 2019

Lithium-ion batteries - powering the EVs of the future

In a recent blog, Eleanor Maciver reviewed a variety of promising “batteries of the future”. Of ...

Graphene Hackathon
Matthew Smith - November 18, 2019

Graphene Hackathon

16-17 November 2019 saw a momentous occasion: innovators, creators and thinkers came together for ...

Meet the team: Richard Clegg, Partner, European Patent Attorney, Patent Attorney Litigator
Richard Clegg - November 15, 2019

Meet the team: Richard Clegg, Partner, European Patent Attorney, Patent Attorney Litigator

As part of our 'meet the team' series, we talk to Richard Clegg about his journey to becoming a ...

New report launched: EPO Opposition Trends in the Life Sciences Sector
Maria Hall - November 14, 2019

New report launched: EPO Opposition Trends in the Life Sciences Sector

Our new research has revealed several recent patterns regarding the European Patent Office ...

Meet the team: Chris Denison, Partner, European Patent Attorney
Chris Denison - November 12, 2019

Meet the team: Chris Denison, Partner, European Patent Attorney

As part of our 'meet the team' series, we talk to Chris Denison about his journey to becoming a ...

Using IP to secure opportunities in the budding medical cannabis sector
Callum McGuinn - November 12, 2019

Using IP to secure opportunities in the budding medical cannabis sector

The opportunities for innovation in medical cannabis dovetails with the opportunity to obtain ...

Top tips for patenting antibodies in Europe
Rebecca Tollervey - November 11, 2019

Top tips for patenting antibodies in Europe

Antibody development is a mature field of technology. There are relatively few new targets, and the ...

Extreme fast charging – the future of electric vehicle batteries
Simon Parry - November 11, 2019

Extreme fast charging – the future of electric vehicle batteries

With global deployment now exceeding five million, electric vehicles continue to hold the promise ...

Oppositions a case to remember: we forced a fuller view of technical features
Seán Walton - November 11, 2019

Oppositions a case to remember: we forced a fuller view of technical features

Case 1 – T 1859/08 ( EPO Board of Appeal, 5 June 2016)

Meet The Team: Simon Kiddle, Partner, European Patent Attorney
Simon Kiddle - November 8, 2019

Meet The Team: Simon Kiddle, Partner, European Patent Attorney

As part of our 'meet the team' series, we talk to Simon Kiddle about his journey to becoming a ...

Coffee capsules: greener grounds
Andrew Pitts - November 6, 2019

Coffee capsules: greener grounds

Large consumer companies are increasingly focusing on reworking their consumable products to be ...

Meet The Team: Katherine Green, Partner, European Patent Attorney
Katherine Green - November 5, 2019

Meet The Team: Katherine Green, Partner, European Patent Attorney

As part of our 'meet the team' series, we talk to Katherine Green about her journey to becoming a ...

Printing the unprintable – new technique expands graphene printing to previously unsuitable substrates
Niles Beadman - October 30, 2019

Printing the unprintable – new technique expands graphene printing to previously unsuitable substrates

Printing with graphene is a large and growing field, representing a highly promising range of ...

EPO Bioinformatics Roadshow
Camille Terfve - October 30, 2019

EPO Bioinformatics Roadshow

There is still a relatively prevalent view in the field of bioinformatics and medical informatics ...

Plastics recycling: polymers unzipped
Alexander Cavell - October 30, 2019

Plastics recycling: polymers unzipped

As society becomes more aware of the adverse effects of single-use plastics on the environment, ...

Oppositions - a case to remember. Flexibility around added matter
Katherine Green - October 30, 2019

Oppositions - a case to remember. Flexibility around added matter

Case 2 – T 0099/13 (EPO Board of Appeal, 14 January 2016)

Chambers & Partners Legal Guide 2019
Jacqueline Murphy - October 29, 2019

Chambers & Partners Legal Guide 2019

We are delighted to report that Mewburn Ellis has once again been ranked in Chambers & Partners ...

Mewburn Ellis: top tier firm Legal 500 2019
Jacqueline Murphy - October 29, 2019

Mewburn Ellis: top tier firm Legal 500 2019

We are delighted to have been ranked as a top tier firm in the 2019 edition of Legal 500. This ...

Lateral partner hire into our new Patent Director role
Maria Hall - October 28, 2019

Lateral partner hire into our new Patent Director role

We are pleased to announce the lateral hire of Paul Misselbrook, previously a partner at Venner ...

Meet The Team: Emily Hayes, Partner, European Patent Attorney
Emily Hayes - October 28, 2019

Meet The Team: Emily Hayes, Partner, European Patent Attorney

As part of our 'meet the team' series, we talk to Emily Hayes about her journey to becoming a ...

FRAND Licensing of SEPs in the age of connected cars
Christoph Moeller - October 26, 2019

FRAND Licensing of SEPs in the age of connected cars

Cars are developing more and more into computerized mobile platforms. They relieve the driver of ...

Employing CRISPR to expose ‘hiding’ cancer cells to immunotherapy
Sean Constable - October 25, 2019

Employing CRISPR to expose ‘hiding’ cancer cells to immunotherapy

Immunotherapy employs the patient’s immune system against cancer. There are various types of ...

Renewable energy – huge potential for biofuel innovation
Thomas Driver - October 23, 2019

Renewable energy – huge potential for biofuel innovation

It has been widely reported in the media recently that we need to do more to address the way in ...

Controlling genes – the new field of epitranscriptomics
Nick Sutcliffe - October 21, 2019

Controlling genes – the new field of epitranscriptomics

The human genome contains roughly 20,000 genes that encode proteins. In order for the cells and ...

Infecting the infection to tackle the rise in chemical antibiotic resistance
Andrew Pitts - October 16, 2019

Infecting the infection to tackle the rise in chemical antibiotic resistance

In previous blogs we have highlighted how certain families of bacteria are highly resistant to ...

Consumable consumables: the edible water bottle
Niles Beadman - October 9, 2019

Consumable consumables: the edible water bottle

Throughout the 20th century, plastic has become increasingly prevalent in our everyday lives. To ...

Inventive AI: can machines innovate?
Richard Johnson - October 7, 2019

Inventive AI: can machines innovate?

The integration of technology based on artificial intelligence into our everyday lives continues ...

5 top tips to prevent trade mark ‘genericide’
Rebecca Anderson-Smith - October 2, 2019

5 top tips to prevent trade mark ‘genericide’

Most trade mark owners will be aware that their UK or European Union trade mark registration is ...

AMR - a global threat
Julie Carlisle - September 27, 2019

AMR - a global threat

A hot topic on everyone’s lips at the moment is Climate Change and its predicted impact on our way ...

T cell engagers - dark horses of immunotherapy
Adam Gregory - September 26, 2019

T cell engagers - dark horses of immunotherapy

Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in ...

Budding opportunities for pharma
Callum McGuinn - September 26, 2019

Budding opportunities for pharma

With shifting attitudes surrounding cannabis-based drugs, it is essential to explore the array of ...

From data to drugs - a brief introduction to AI in drug discovery
Joseph Newcombe - September 25, 2019

From data to drugs - a brief introduction to AI in drug discovery

The road to an approved drug is well known to be an arduous journey. Recent estimates put the cost ...

Strict and inflexible: material claims at the EPO
Matthew Smith - September 24, 2019

Strict and inflexible: material claims at the EPO

Innovators in advanced materials can face an uphill struggle to get suitable patent protection at ...

Obtaining patent protection for fermentation processes and products – the European perspective
Tanis Keirstead - September 19, 2019

Obtaining patent protection for fermentation processes and products – the European perspective

Fermented foods have been known for millennia and form an important part of many national cuisines. ...

Batteries for the future: the sky may not be the limit!
Eleanor Maciver - September 18, 2019

Batteries for the future: the sky may not be the limit!

In an earlier blog Sam Bailey discussed the growing demands for high performance battery ...

Cannabis: on to greener pastures?
Callum McGuinn - September 17, 2019

Cannabis: on to greener pastures?

Callum McGuinn, explores the history of social attitudes towards cannabis and asks what the future ...

Intermodality: the future of transport?
Christoph Moeller - September 13, 2019

Intermodality: the future of transport?

Search the term 'intermodality' and you'll turn up a number of definitions and some fine ...

Food of the future – regulating and protecting gene-edited crops
Simon Kremer - September 11, 2019

Food of the future – regulating and protecting gene-edited crops

A recent episode of the BBC World Service’s excellent series “50 Things that made the modern ...

When AI met EQ
Richard Johnson - September 6, 2019

When AI met EQ

Affective computing may be a multi-billion -dollar business, but much of how it works remains ...

DIY biology dilemma – regulating biohacking
Camille Terfve - September 4, 2019

DIY biology dilemma – regulating biohacking

Science kits may have inspired generations of children to become scientists, and those grown up ...

Printing with graphene: exploring the inks set to unleash graphene's potential
Matthew Naylor - August 30, 2019

Printing with graphene: exploring the inks set to unleash graphene's potential

Graphene has been widely heralded as a game-changer in the research and development of new ...

Shifting treatments: cancer as a manageable disease
Nick Sutcliffe - August 29, 2019

Shifting treatments: cancer as a manageable disease

As new treatments drive a shift towards treating cancer as a manageable disease we are seeing ...

Fast times at TBRe: the future of autonomous vehicles
Simon Parry - August 20, 2019

Fast times at TBRe: the future of autonomous vehicles

In Forward magazine edition 2, we met up with Team Bath Racing Electric (TBRe) who are driving the ...

Team Bath Racing Electric - zooming through 2019
Simon Parry - August 19, 2019

Team Bath Racing Electric - zooming through 2019

Each year, over 100 university engineering teams from around the globe travel to Silverstone, ...

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance
Camille Terfve - August 15, 2019

Patentable subject matter in bioinformatics - USPTO’s January 2019 guidance

In this article, Paul Liu and Ashley Barton from Duane Morris LLP provided some interesting ...

Understanding Europe’s trade secret rules
Sean Jauss - August 13, 2019

Understanding Europe’s trade secret rules

Companies invest in developing or acquiring intellectual capital to gain a competitive or ...

Challenges Post­ Selex
Richard Clegg - August 13, 2019

Challenges Post­ Selex

Twenty-five years ago Tuerk and Gold reported the Selex method. Being the first European patent ...

USPTO changes rules of representation for overseas trade mark applicants
Andy King - August 12, 2019

USPTO changes rules of representation for overseas trade mark applicants

The US Patent and Trademark Office (“USPTO”) has recently changed the rules regarding the need for ...

A case in point - Trunki vs Kiddee
Tom Furnival - August 7, 2019

A case in point - Trunki vs Kiddee

Rob Law, the founder and chief executive of Magmatic who make the Trunki product, said that the ...

Speeding things up at the EPO
Eleanor Maciver - August 7, 2019

Speeding things up at the EPO

There are many reasons why an applicant may wish to speed up the prosecution of an application. For ...

The rise of predictive medicine
Frances Salisbury - August 5, 2019

The rise of predictive medicine

Thanks to significant advances in genetics, we are not only getting better at diagnosing disease, ...

Circular economy: new technologies rise to the challenge
Eleanor Maciver - August 2, 2019

Circular economy: new technologies rise to the challenge

In recent months there has been a rapid increase in publicity and public awareness of ...

Green graphene - the pursuit of sustainability
Matthew Smith - July 31, 2019

Green graphene - the pursuit of sustainability

Theoretically, at least, graphene can be produced from any carbon source. While the pursuit of ...

Cultural (mis)appropriation in trademarks: can (and should) you register culturally sensitive names?
Andy King - July 31, 2019

Cultural (mis)appropriation in trademarks: can (and should) you register culturally sensitive names?

Andy King, Partner and Trademark Attorney at Mewburn Ellis, discusses the controversial issue of ...

The rise of e-scooters - micromobility gains momentum
Christoph Moeller - July 31, 2019

The rise of e-scooters - micromobility gains momentum

As congestion in cities rises, existing transportation can no longer keep up with growing ...

New European spirit drinks regulation EU 2019/787
Andy King - July 24, 2019

New European spirit drinks regulation EU 2019/787

Dydra Donath breaks down the new regulation the EU has placed on spirit drink trademarks. Article ...

Cultured meat - food for thought
Adam Gregory - July 23, 2019

Cultured meat - food for thought

Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products ...

EPO Quality Report 2018
Tom Furnival - July 12, 2019

EPO Quality Report 2018

July has seen the publishing of the European Patent Office’s (EPO) 2018 Quality Report. This is the ...

New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?
Emily Hayes - July 9, 2019

New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?

Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council ...

A Myriad of effects
Emily Hayes - July 5, 2019

A Myriad of effects

Even though the decision in Myriad is now 6 years old and there have been several follow-on cases, ...

Charging into the future - the increasing demands on battery technologies
Sam Bailey - June 27, 2019

Charging into the future - the increasing demands on battery technologies

Battery technology is an area of constant innovation. For years we have been trying to squeeze a ...

Data and security issues in a world of connected cars
Christoph Moeller - June 26, 2019

Data and security issues in a world of connected cars

Mobility patterns are changing and technological innovations in electrification, connectivity and ...

Gender medicine – deriving novelty from treating women?
Frances Salisbury - June 26, 2019

Gender medicine – deriving novelty from treating women?

When you hear the term “gender medicine”, what comes to mind? For many people, the term is ...

Three-stripes and you’re out: Adidas lose trade mark battle
Kate O'Rourke - June 21, 2019

Three-stripes and you’re out: Adidas lose trade mark battle

Adidas’ famed three-stripe logo has been deemed as lacking “distinctive character”. The General ...

Singapore biotech start-ups: the importance of patent protection
Adam Gregory - June 21, 2019

Singapore biotech start-ups: the importance of patent protection

Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is ...

Tips from the top: inspiring women in technology
Anna Mudge - June 19, 2019

Tips from the top: inspiring women in technology

You may be surprised to hear that only 17% of those working in Technology in the UK are female. ...

Medicinal cannabis: recent changes and future innovations
Callum McGuinn - June 18, 2019

Medicinal cannabis: recent changes and future innovations

Government policy on the prescription of cannabis-derived medicines has undergone some interesting ...

Managing Intellectual Property: IP Stars 2019
Jacqueline Murphy - June 17, 2019

Managing Intellectual Property: IP Stars 2019

We are delighted to be ranked in Managing Intellectual Property: IP Stars for 2019.

IAM Patent 1000, 2019
Jacqueline Murphy - June 17, 2019

IAM Patent 1000, 2019

We are delighted to be ranked highly recommended in ‘IAM 1000: The World’s Leading Patent ...

Conducting due diligence and audits on intellectual property rights
Sean Jauss - June 14, 2019

Conducting due diligence and audits on intellectual property rights

You conduct due diligence of intellectual property (IP) rights to check what is being sold or ...

EU approves first gene therapy for patients with a mild form of β-Thalassemia
Frances Salisbury - June 4, 2019

EU approves first gene therapy for patients with a mild form of β-Thalassemia

Exciting news in the personalised medicine space – the EU has just approved the first gene therapy ...

The journey of rLoop - a new technology innovation network disrupting the world of transport and IP
Graeme Moore - May 29, 2019

The journey of rLoop - a new technology innovation network disrupting the world of transport and IP

As a child growing up in Blackburn, near Manchester, UK, Ilyas Vali dreamed of owning a dog. He ...

A single to Singapore please: the rise in on-demand bus services
Christoph Moeller - May 24, 2019

A single to Singapore please: the rise in on-demand bus services

Discussion about future mobility tends to focus on the strategies of the major car manufacturers ...

Glen Buchenbach - Scotch whisky?
Andy King - May 20, 2019

Glen Buchenbach - Scotch whisky?

Originally published in The Trademark Lawyer, Dydra Donath discusses the recent CJEU decision on ...

Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable
Julie Carlisle - May 20, 2019

Protecting the ‘Trojan horse’ drug key to keeping a struggling field viable

An Expert View column originally published in The Pharma Letter. Read the original article here. ...

Precision therapeutics for the precision medicine era
Adam Gregory - May 17, 2019

Precision therapeutics for the precision medicine era

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic ...

Personalised medicine: patient stratification
Simon Kiddle - April 29, 2019

Personalised medicine: patient stratification

While the general idea of customising treatment to patients is not new, the degree to which ...

Pioneers of precision medicine
Frances Salisbury - April 15, 2019

Pioneers of precision medicine

Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical ...

AIPLA Women in IP Global Networking Event: Manchester 4 April 2019
Jacqueline Murphy - April 10, 2019

AIPLA Women in IP Global Networking Event: Manchester 4 April 2019

On Thursday 4 April, we were delighted to host an American Intellectual Property Law Association ...

Hydrogen fuel cell vehicles: growth and innovation
Simon Parry - April 5, 2019

Hydrogen fuel cell vehicles: growth and innovation

While much attention and noise has surrounded the growth in the number of electric and plug-in ...

Hydrogen: the storage question
Matthew Smith - April 4, 2019

Hydrogen: the storage question

There’s a lot to like about hydrogen. It’s light; it’s abundant (at least atomically - water and ...

Babybel trade mark blow
Rebecca Anderson-Smith - April 3, 2019

Babybel trade mark blow

The UK Intellectual Property Office (UKIPO) has dealt a blow to the owners of Babybel cheese, ...

Partner promotions and new Director position
Maria Hall - April 1, 2019

Partner promotions and new Director position

We are delighted to announce that Sarah Kostiuk-Smith, Jacqueline Pang and Eliot Ward have been ...

The road to autonomous
Christoph Moeller - March 28, 2019

The road to autonomous

In a recent article published in Intellectual Property Magazine, Christoph Moeller explores the ...

Advanced materials: game-changing graphene
Matthew Smith - March 28, 2019

Advanced materials: game-changing graphene

In the 15 years since Professors Andre Geim and Konstantin Novoselov isolated and discovered ...

Dosage regimen patents: bruised but not beaten
Julie Carlisle - March 28, 2019

Dosage regimen patents: bruised but not beaten

Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent ...

Playing for time: strategies that can help extend a drug's patent life
Emily Hayes - March 25, 2019

Playing for time: strategies that can help extend a drug's patent life

In our new magazine Forward, we interview C Hunter Baker of Wolf, Greenfield & Sacks PC. Hunter ...

Numbering system for re-registered design rights and comparable trade marks
Robert Watson - March 21, 2019

Numbering system for re-registered design rights and comparable trade marks

The UK enacted the EU Withdrawal Act 2018 which provides the basis for how EU law will be converted ...

Former CITMA President Kate O’Rourke to head our European trade mark services
Maria Hall - March 11, 2019

Former CITMA President Kate O’Rourke to head our European trade mark services

We are delighted to announce that Kate O’Rourke will join the firm on 1 April 2019.

EPO oral proceedings in Haar - do they infringe a party’s right to be heard? 
Sean Constable - March 6, 2019

EPO oral proceedings in Haar - do they infringe a party’s right to be heard? 

A new referral to the Enlarged Board raises this question... The right to be heard under Article ...

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences
Frances Salisbury - February 27, 2019

Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences

We are entering an age of precision medicine, with patients receiving tailored treatments, selected ...

How to patent AI technology at the EPO
Emma Graham - February 26, 2019

How to patent AI technology at the EPO

Once only a figment of the imagination in literature such as Mark Shelley’s Frankenstein, ...

Self-driving vehicles: what do consumers think (and want)?
Simon Parry - February 25, 2019

Self-driving vehicles: what do consumers think (and want)?

As a survey of 25,000 consumers in 20 countries, and a study that has been conducted annually over ...

Is your interest legitimate? New referral to the EBOA on double patenting
Simon Kiddle - February 22, 2019

Is your interest legitimate? New referral to the EBOA on double patenting

EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the ...

Building an IP portfolio: Nine tips for success
Matthew Smith - February 15, 2019

Building an IP portfolio: Nine tips for success

Companies need to think carefully about how they protect, manage and leverage the various ...

Plant related inventions: clarity at last?
Thomas Driver - February 6, 2019

Plant related inventions: clarity at last?

As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial ...

Fighting cancer with CAR-T therapies
Frances Salisbury - February 4, 2019

Fighting cancer with CAR-T therapies

In September 2018, NHS England entered into an agreement with Novartis to offer its CAR-T therapy, ...

WTR 1000 2019 - The World’s Leading Trademark Professionals
Jacqueline Murphy - February 4, 2019

WTR 1000 2019 - The World’s Leading Trademark Professionals

We are delighted to have been named as a recommended firm in the World Trademark Review 2019 ...

Commercialising genomic research in the US: tips for obtaining patent protection
Emily Hayes - January 30, 2019

Commercialising genomic research in the US: tips for obtaining patent protection

The field of genomics has seen incredible advances over the past few decades. Technological ...

China - a key player in the global precision medicine race
Frances Salisbury - January 30, 2019

China - a key player in the global precision medicine race

With a growing economy, and a large, ageing population, China is attracting attention from global ...

Google issued with €50 million fine by CNIL for data protection practices
Emma Kennaugh-Gallacher - January 28, 2019

Google issued with €50 million fine by CNIL for data protection practices

The French counterpart to our own Information Commissioner, the Commission nationale de ...

Autonomous driving: the IP twists and turns
Christoph Moeller - January 28, 2019

Autonomous driving: the IP twists and turns

Autonomous driving (AD) is on everyone’s lips when it comes to the next big thing in the automotive ...

Autonomous vehicles - the race to innovate
Simon Parry - January 22, 2019

Autonomous vehicles - the race to innovate

The future of the automotive sector will be fundamentally different from its past. Electric ...

Eight key themes from the J.P. Morgan Healthcare Conference
Sean Jauss - January 14, 2019

Eight key themes from the J.P. Morgan Healthcare Conference

I’ve spent the last few days talking with biotech entrepreneurs, VC fund managers and lawyers ...

Blockchain: the next patent boom
Graeme Moore - December 13, 2018

Blockchain: the next patent boom

Emma Graham and Graeme Moore attended the EPO’s “Patenting Blockchain” conference in The Hague – ...

Precision medicine: ethics, regulation and patent law
Frances Salisbury - December 13, 2018

Precision medicine: ethics, regulation and patent law

New genomic and proteomic analysis technologies allow for diagnosis and prognosis of patients with ...

Future mobility: the new direction of transport
Christoph Moeller - December 11, 2018

Future mobility: the new direction of transport

Massive social, economic and technology trends are converging to change mobility - how we move ...

Plant related inventions: the saga continues
Frances Salisbury - December 10, 2018

Plant related inventions: the saga continues

We may be approaching the end of the year, but the saga of patents for plant related inventions at ...

Patent protection: five tips for biotech start-ups
Adam Gregory - December 10, 2018

Patent protection: five tips for biotech start-ups

Early-stage biotech companies are often founded based on the exciting results of pre-clinical ...

Clovis Oncology success in European Opposition Proceedings related to Rubraca®
Richard Clegg - December 10, 2018

Clovis Oncology success in European Opposition Proceedings related to Rubraca®

Clovis Oncology has announced that the European Patent Office (EPO) last week upheld claims of ...

Significant blow to Cadbury in purple trade mark battle
Rebecca Anderson-Smith - December 6, 2018

Significant blow to Cadbury in purple trade mark battle

Cadbury has been dealt a blow by the Court of Appeal in its battle to maintain its trade mark for ...

Supreme Court decision signals bad news for patent holders
Nick Sutcliffe - November 14, 2018

Supreme Court decision signals bad news for patent holders

The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a ...

Our Cambridge Office moves to prestigious Innovation Park
Shaun Harvey - November 8, 2018

Our Cambridge Office moves to prestigious Innovation Park

Our Cambridge office moved on 26 November to the prestigious St John’s Innovation Park at the ...

Precision Medicine: the next revolution in healthcare
Frances Salisbury - October 31, 2018

Precision Medicine: the next revolution in healthcare

In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in ...

Morphosis: creating and nurturing biotech start-ups in Singapore
Richard Clegg - October 31, 2018

Morphosis: creating and nurturing biotech start-ups in Singapore

We understand that early-stage biotech companies do not have it easy. It is a long road from ...

Team Bath Racing Electric: racing to success
Simon Parry - October 30, 2018

Team Bath Racing Electric: racing to success

Team Bath Racing Electric (TBRe) achieved their best ever ranking at the 2018 Formula Student UK ...

Development in the war on superbugs
Matthew Smith - October 29, 2018

Development in the war on superbugs

The spread of antibiotic-resistant infections is one of the most serious threats in modern ...

Graphene: a whole new '2D world'
Matthew Smith - October 25, 2018

Graphene: a whole new '2D world'

Graphene has been heralded as a game changer in the research and development of new materials since ...

Patenting board games and puzzles
Graeme Moore - October 19, 2018

Patenting board games and puzzles

Quite a lot of people think of new games and puzzles, and wonder whether patenting would help them ...

JIPA 2018 European Seminar
Matthew Smith - October 8, 2018

JIPA 2018 European Seminar

The Japanese Intellectual Property Association (JIPA) has been promoting fair and effective ...

The pioneering work of Professor Sir Greg Winter
Seán Walton - October 3, 2018

The pioneering work of Professor Sir Greg Winter

Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of ...

Life as a trainee patent attorney
Sean Constable - October 2, 2018

Life as a trainee patent attorney

Sean Constable, trainee patent attorney in our life sciences patent team, joined Mewburn Ellis as ...

Our growth story
Shaun Harvey - October 1, 2018

Our growth story

The last 12 months have seen a period of remarkable growth and development for the firm. In ...

Navigating the Brexit landscape: patents
Robert Watson - September 27, 2018

Navigating the Brexit landscape: patents

The existing European patent system was unaffected by the UK leaving the EU earlier in 2020, and by ...

Roger Federer in trade mark dispute with Nike
Jacqueline Pang - July 20, 2018

Roger Federer in trade mark dispute with Nike

Roger Federer recently left Nike and signed a deal with Uniqlo reportedly worth $30million per ...

Our new brand: the forward-looking IP firm
Maria Hall - July 9, 2018

Our new brand: the forward-looking IP firm

Mewburn Ellis is a name synonymous with quality in the IP space. We are also seen as a firm that ...

Changes to inter partes review system for challenging granted patents
Simon Kremer - April 30, 2018

Changes to inter partes review system for challenging granted patents

Last week, the U.S. Supreme Court issued two important decisions relating to inter partes review ...

ECJ provides clarity on the application of Article 8(1) of the Community Design Regulation
Richard Johnson - April 26, 2018

ECJ provides clarity on the application of Article 8(1) of the Community Design Regulation

Europe’s highest court, the European Court of Justice (ECJ), recently handed down a decision in ...

Celebrating women working in IP in the North West
Anna Mudge - April 20, 2018

Celebrating women working in IP in the North West

On Thursday 19 April, we were proud hosts of an American Intellectual Property Law Association ...

UK Supreme Court Establishes Doctrine of Equivalents in Actavis v Lilly
Callum Anderson - August 1, 2017

UK Supreme Court Establishes Doctrine of Equivalents in Actavis v Lilly

In many jurisdictions a product or process may be held to infringe even though it falls outside the ...

Previous 1 2 Next

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy